Allogene Therapeutics (ALLO) FCF Margin (2021 - 2026)
Allogene Therapeutics' FCF Margin came in at -692.80% for Q2 2026.
Powered by 
Analysis
Allogene Therapeutics (ALLO) FCF Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Allogene Therapeutics reported FCF Margin of -2211.16%; for FY2024, it came in at -913609.09%, down 661768.04 percentage points from FY2023.
- FCF Margin has declined in each of the last three years, with a three-year change of -913428.30 percentage points (FY2021 to FY2024).
- Going back by year, FCF Margin was -251841.05% in FY2023 (-107155.16 pp), -144685.90% in FY2022 (-144505.11 pp) and -180.79% in FY2021.
- The Q2 2026 figure represents the highest quarterly FCF Margin since Q4 2021.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2022 (a gain of 49743.89 percentage points), and the weakest in Q4 2022 (a drop of 245277.43 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Allogene Therapeutics | 562.91 Mn | 562.91 Mn | - | -692.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -692.80% |
| Mar 31, 2024 | -254,122.73% |
| Dec 31, 2023 | -256,609.52% |
| Sep 30, 2023 | -252,463.64% |
| Jun 30, 2023 | -282,477.27% |
| Mar 31, 2023 | -225,580.00% |
| Dec 31, 2022 | -245,338.46% |
| Sep 30, 2022 | -177,325.93% |
| Jun 30, 2022 | -68,601.56% |
| Mar 31, 2022 | -179,843.59% |
| Dec 31, 2021 | -61.03% |
| Sep 30, 2021 | -106,581.63% |
| Jun 30, 2021 | -118,345.45% |
| Mar 31, 2021 | -145.49% |
API Access
Allogene Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();